STERIS (NYSE:STE – Get Rating) had its price target boosted by stock analysts at Piper Sandler from $197.00 to $200.00 in a research report issued on Friday, The Fly reports. Piper Sandler’s target price would suggest a potential downside of 5.15% from the stock’s previous close.
Other equities analysts have also recently issued reports about the stock. StockNews.com assumed coverage on shares of STERIS in a research report on Thursday, March 16th. They issued a “buy” rating for the company. KeyCorp upped their price objective on shares of STERIS from $210.00 to $235.00 in a research report on Friday. TheStreet raised shares of STERIS from a “c” rating to a “b-” rating in a research report on Wednesday. JMP Securities reduced their price target on shares of STERIS from $250.00 to $240.00 and set a “market outperform” rating on the stock in a research report on Wednesday, February 15th. Finally, Stephens reaffirmed an “overweight” rating and set a $220.00 price target on shares of STERIS in a research report on Thursday, February 9th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $226.40.
STERIS Trading Up 1.4 %
Shares of STE opened at $210.85 on Friday. The stock has a fifty day moving average of $187.26 and a two-hundred day moving average of $187.64. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.61 and a current ratio of 2.48. The company has a market capitalization of $20.93 billion, a PE ratio of 197.06, a price-to-earnings-growth ratio of 1.97 and a beta of 0.85. STERIS has a fifty-two week low of $159.21 and a fifty-two week high of $236.10.
Institutional Trading of STERIS
Institutional investors have recently bought and sold shares of the company. 1832 Asset Management L.P. acquired a new position in STERIS in the first quarter worth approximately $25,000. Delta Asset Management LLC TN bought a new position in STERIS in the fourth quarter worth $27,000. Fiduciary Alliance LLC bought a new position in STERIS in the fourth quarter worth $28,000. Asset Dedication LLC acquired a new position in STERIS during the fourth quarter worth $30,000. Finally, Pinnacle Financial Partners Inc. acquired a new position in STERIS during the third quarter worth $33,000. Institutional investors and hedge funds own 92.35% of the company’s stock.
STERIS Company Profile
STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites.
- Get a free copy of the StockNews.com research report on STERIS (STE)
- MarketBeat Week in Review – 5/8 – 5/12
- An Updraft Is Brewing For DraftKings
- PepsiCo Hits “Sweet Spot” For APAC Growth, Macros Agree
- High-Risk Mullen Automotive Continues To Build Momentum
- 3 Recession-Proof Stocks With Nice Dividends
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.